FDA NDC Directory · JSON-LD · Markdown

Bimzelx

NDC 50474-780 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namebimekizumab
Labeler / ManufacturerUCB, Inc.
Marketing categoryBiologic License Application · App BLA761151
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsBIMEKIZUMAB (160 mg/mL)
Marketing started20231017
Package count2

External sources

Source: openFDA. Public-domain (CC0).